Journal of Cellular & Molecular Anesthesia
Journal Overview
The Journal of Cellular & Molecular Anesthesia (JCMA), published by Brieflands, is dedicated to advancing knowledge in anesthesiology and perioperative medicine through high-quality, peer-reviewed research. The journal bridges the gap between laboratory findings and clinical applications with a focus on translational studies, cellular and molecular mechanisms, and personalized approaches to anesthetic care. JCMA publishes original research, systematic reviews, meta-analyses, case reports, and other article types, fostering innovation and collaboration in the field of cellular and molecular anesthesiology.
Abstracted/Indexed: Scopus | EMBASE | ISC | ROAD | Google Scholar,
Scope: Translational Anesthesiology, Disease-Oriented Research, Bench-to-Bedside Studies, Molecular and Cellular Anesthesia, Personalized Anesthesiology, Perioperative Medicine
Copyright Policy: CC BY-NC 4.0
Access Policy: Open Access
Peer Review Policy: Double-Blind Peer Review System & Open Peer Review
Recent Articles
Explore the latest articles published in this journal for impactful research and the newest advancements in the field.
The Impact of Olfactory Dysfunction on Post-operative Cognitive Dysfunction and Delirium: A Systematic Review
,,,,,
Assessment of STOP-Bang Test Ability to Predict Postoperative Respiratory and Airway Complications of Supratentorial Craniotomy
,,,,
Is Inferior Alveolar Nerve Block Beneficial in Fracture Mandibular Surgeries? A Randomized Controlled Trial
*,,,
Impact of Pulsed Radiofrequency on Activated Dorsal Root Ganglion Neuronal Dynamics
Comparison Between Ultrasound-Guided Erector Spinae Plane Block and Ultrasound-Guided Caudal Analgesia in Pediatric Cancer Patients Undergoing Surgical Resection of Renal and Suprarenal Tumors: A Randomized Clinical Trial
,
Effect of Dexmedetomidine on Stress-Induced Changes in Hemodynamic and Left Ventricular Function in Coronary Artery Bypass Grafting Surgery: A Randomized Controlled Trial
*,,,
Journal Metrics
Discover our most recent insights and updates.
